|
oral anti-Parkinson's drugs Clinical Trials
1 actively recruiting trial
Pipeline
Early 1: 1
Top Sponsors
- Zhujiang Hospital1
Indications
- Onabotulinumtoxin A1
- Parkinson's Disease1
- Overactive Bladder1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.